UpNAT_node Profile Banner
UK Platform for Nucleic Acid Therapies- UPNAT Profile
UK Platform for Nucleic Acid Therapies- UPNAT

@UpNAT_node

Followers
92
Following
18
Media
27
Statuses
45

Creating a national network of experts/stakeholders to facilitate & promote the development of Nucleic Acid Therapies for patients with rare diseases in the UK

MRC / NIHR
Joined November 2023
Don't wanna be here? Send us removal request.
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
5 months
Today, on #RareDiseaseDay, we are happy to share the @DHSCgovuk newly published 2025 England Rare Disease action plan - exciting work ahead for the @UpNAT_node!.#RareDiseaseDay #RareDiseaseDay2025 #RareDisease
Tweet media one
0
0
1
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
5 months
12 PhDs on Antisense oligonucleotide #research to foster the full therapeutic potential of antisense technology across tissues 11 posts across Europe, the other at UCL under @UpNAT_node Director Haiyan Zhou @lab_zhou
Tweet media one
0
0
3
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
7 months
UPNAT Director Haiyan Zhou is keynote speaker at the upcoming Cambridge Chem&Bio Seminar on Nucleic Acid Research. @lab_zhou @UpNAT_node .Space is available on 14 Dec "whether you're a student, researcher, or simply curious about the field", book here:
0
2
5
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
8 months
Congrats to Carlo Rinaldi @rinaldi_ca, awarded title of Professor of Molecular & Translational Neuroscience @UniofOxford Institute of Developmental & Regenerative Medicine. Carlo is @UpNAT_node PI, streamlining NAT clinical trials & regulatory approval.
0
1
6
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
9 months
The Oxford-Harrington Rare Disease Centre has announced inaugural 2024 Rare Disease Scholar award recipients, which includes two members of the @UpNAT_node team. Well done Haiyan Zhou and Carlo Rinaldi on this notable achievement! @OHRareDisease @lab_zhou @rinaldi_ca @RDRUKHub.
2
1
8
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
9 months
Join the @UpNAT_node team! .Applications for the Child Health Research (CHR) PhD Studentships for 25/26 are open. Deadline for students to apply is 09:00 Friday 13th December.
Tweet media one
0
2
2
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
9 months
An interesting paper to contextualise the recent published guidelines by the Dutch Center for RNA Therapeutics.@oligogirl @LaufferMarlen @roon_mom #raredisease.
0
1
1
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
9 months
RT @LaufferMarlen: @oligogirl @timyu @UpNAT_node @BeijerDanique @aubriesoucy The guidelines are accompanied by training videos and test var….
0
2
0
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
10 months
Impressive work by the Dutch Center for RNA Therapeutics! Thanks to @LaufferMarlen for the opportunity to participate in this ASO guideline development, with @UpNAT_node co-authors @aliceedavidson and @MinaRyten #DCRT.
0
2
3
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
10 months
We shared the excitement as Haiyan Zhou @lab_zhou presented an update on her research as Harrington Scholar @HarringtonDI_UH. And appreciated the introduction to our @UpNAT_node! .#OxfordHarrington2024 @OHRareDisease @RDRUKHub #RareDisease
Tweet media one
0
3
13
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
10 months
UPNAT Node partner Prof Carlo Rinaldi chairs an excellent session at the #OxfordHarrington2024 Rare Disease Centre Symposium. Full agenda here: @rinaldi_ca @OHRareDisease @UniofOxford @UpNAT_node
Tweet media one
0
0
2
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
10 months
Excellent speakers lined up for the Oxford-Harrington Rare Disease Centre  Symposium later this month (including @UpNAT_node Director Haiyan Zhou) .Registration is open:.#RareDiseases @lab_zhou @OHRareDisease
Tweet media one
0
0
4
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
10 months
RT @RDRUKHub: 📢Our 2nd Annual Conference is happening on 25th March 2025! Mark your calendars and join us in #Manchester. 🔔Stay tuned for m….
0
3
0
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
1 year
RT @OTSociety: Join us for an insightful webinar on "A Nucleic Acid Approach to Antibody Therapeutics" on July 18th. Dr. John Chaput will….
0
2
0
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
1 year
RT @UpNAT_node: Join the @UpNAT_node team! Now hiring: our candidate will have a PhD degree in biomedical sciences or closely related areas….
0
8
0
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
1 year
Buzzing crowd at yesterday's Genomics England Research Summit, where @MinaRyten contributed to the "Therapeutic Innovations and Trials" session with an introduction to our @UpNAT_node. @GenomicsEngland #RareDisease #gers2024
Tweet media one
0
1
4
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
1 year
UPNAT Director Haiyan Zhou @lab_zhou will be speaking tomorrow alongside UK DRI Director Mina Ryten @MinaRyten at the @GenomicsEngland Summit about the @UpNAT_node and enhancing rare disease treatment:
Tweet media one
0
2
8
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
1 year
Now to build on the momentum of the recent @UpNAT_node Symposium, with the help of our partners across the UK and beyond. With special thanks to @OTSociety who supported PPIE at the event with their generous grant:
Tweet media one
0
0
5
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
1 year
Join the @UpNAT_node team! Now hiring: our candidate will have a PhD degree in biomedical sciences or closely related areas, with strong knowledge & skillset in bioinformatics. Preclinical RNA therapy drug development (ASO, siRNA, mRNA) are highly desired.
Tweet media one
0
8
10
@UpNAT_node
UK Platform for Nucleic Acid Therapies- UPNAT
1 year
We enjoyed excellent participation from the audience at last week's @UpNAT_node Symposium. Our two panels (1- target selection for #raredisease, and 2- #clinicaltrials and regulatory pathway) in particular generated thoughtful & useful discussion. @RDRUKHub @The_MRC @NIHRresearch
Tweet media one
0
1
0